Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging.
Level 5 - mechanism / opinion, no new human data
Bench in vitro cell culture and in vivo mouse xenograft research without human clinical data
PubMed 11593017 · doi:10.1073/pnas.211053698
What was done
Human fibroblasts were induced into senescence via replicative exhaustion, oncogenic RAS, p14(ARF), or hydrogen peroxide, and co-cultured with normal, premalignant, and malignant epithelial cells to measure effects on proliferation. Senescent fibroblasts were also co-injected with epithelial cells into mice to assess tumor formation in vivo, and the contribution of secreted soluble and insoluble factors was evaluated.
What was found
Senescent fibroblasts stimulated proliferation of premalignant and malignant epithelial cells, but not normal epithelial cells. Growth stimulation occurred even when senescent cells made up only 10% of the fibroblast population and was equally robust across all four senescence triggers, mediated in part by soluble and insoluble secreted factors. In mice, co-injection with senescent fibroblasts promoted tumor formation by premalignant and malignant epithelial cells far more than presenescent fibroblasts. Specific numerical metrics and sample sizes were not reported in the abstract.
Why it matters
This study provides an experimental model of evolutionary antagonistic pleiotropy, demonstrating that while cellular senescence suppresses cell-autonomous tumorigenesis, the accumulation of senescent cells and their secretome can paradoxically promote the growth of adjacent transformed cells in aging tissue.
Limits
The findings rely entirely on in vitro cell cultures and mouse xenograft models, which may not fully recapitulate physiological human tissue microenvironments or systemic immune surveillance. Quantitative data, sample sizes, and mouse numbers were not reported in the abstract.
Cited by
- supports Co-injecting premalignant cells with senescent cells into mice converts premalignant cells into full-blown malignancies.